ActualitésAssisté par IA

Uzbekistan and AstraZeneca Explore Bilateral Collaboration in Pharmaceutical Sector

Uzbekistan discusses pharmaceutical collaboration with AstraZeneca to boost local production and investment.

Mrudula Kulkarni
Par Mrudula Kulkarni
Rédacteur en chef - Pharma Now
16 août 2024Updated Jun 26, 2025 · 2 min de lecture
Uzbekistan and AstraZeneca Explore Bilateral Collaboration in Pharmaceutical Sector
https://www.contractpharma.com/contents/view_breaking-news/2022-05-02/astrazeneca-plans-new-rd-center-and-alexion-headquarters/
Journalisme assisté par IA
Reviewed by Mrudula Kulkarni, Rédacteur en chef - Pharma Now

Ravshan Usmanov, Uzbekistan's Extraordinary and Plenipotentiary Ambassador to the UK, met with Nitin Kapoor, AstraZeneca's Deputy Head of Production Expansion, to talk about potential bilateral collaboration. Kapoor gave a summary of AstraZeneca's worldwide operations and research projects with the goal of creating ground-breaking cures for significant illnesses. Usmanov talked about the changes being made to the pharmaceutical industry in Uzbekistan in an effort to increase domestic production capacity and draw in international investment.

Benefits for foreign investors include the opportunity to commission new production facilities and a hospitable business climate. These factors are anticipated to foster an environment that will facilitate AstraZeneca's further expansion in the nation. The discussion ended with a mutual commitment to further develop bilateral ties through visits and meetings in the future, indicating a promising partnership between AstraZeneca and Uzbekistan.

SujetsNews
Mrudula Kulkarni
Written by
Mrudula Kulkarni
Rédacteur en chef - Pharma Now

My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.



Discussion

Chargement de la discussion…

Plus dans Pharma News

Tous les articles →